European Pharmaceutical Review

NOVEMBER 8, 2022

Pharmaceutical manufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions.

Food and Drug Administration 52

Food and Drug Administration Pharma Prescription Manufacturing 52

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt.

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

Clarify Health

OCTOBER 26, 2021

In this blog, we take a close look at health equity in oncology trials specifically, assessing how the lack of diversity and inclusion has impacted cancer patients and the pharma industry’s key initiatives to address it. Clarify launched its real-world evidence on health disparities in 2021.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

Impetus Digital

NOVEMBER 23, 2023

Many of these will discuss the expanding role and capabilities of AI and machine learning in the Pharma space. The new way to engage KOLs at conferences: virtual Ambassador programs To start off the top-5, let’s take a look at how Pharma is shifting the way they engage key opinion leaders (KOLs) at medical congresses and conferences.

Education 52

Education Healthcare Provider Physicians Pharma 52